Novavax Inc (NVAX)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Novavax Inc (NVAX) is listed on Nasdaq, where it has traded since December 5, 1995.
- Listed On
- Nasdaq
- Listed Since
- December 5, 1995
- Employees
- 749
- Market Cap
- $1.8B
About Novavax Inc
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 259 institutions reported holding NVAX, with 117.4 million shares worth $1.1 billion in aggregate. The largest reported holder was Vanguard, with 16.1 million shares worth $152.1 million. Of the 5 largest holders listed below, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Vanguard | 16,148,832 | $152M | Added 3.61% |
| Shah Capital Management | 14,165,577 | $133M | Reduced 4.58% |
| BlackRock | 13,946,881 | $131M | Added 8.58% |
| State Street | 11,740,550 | $111M | Added 30.88% |
| Sanofi | 6,880,481 | $65M | Unchanged |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is NVAX?
Novavax Inc (NVAX) is listed on Nasdaq, where it has traded since December 5, 1995.
Who are the largest institutional holders of NVAX?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of NVAX were Vanguard, Shah Capital Management and BlackRock.
How many institutions own NVAX?
259 institutions reported a position in NVAX for the quarter ended June 30, 2026, worth $1.1 billion in total.
Did institutions buy or sell NVAX last quarter?
Of the 5 largest reported holders, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for NVAX.
Every reported institutional holder, plus insider and congressional trades in NVAX, on SentiSense.